End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
415 KRW | -5.25% | -.--% | -0.72% |
Business Summary
Number of employees: 103
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical Device Distribution
58.3
%
| 54,572 | 57.9 % | 51,573 | 58.3 % | -5.50% |
Dry Food
31.0
%
| 29,919 | 31.7 % | 27,410 | 31.0 % | -8.39% |
Genome Analysis
10.7
%
| 9,752 | 10.3 % | 9,473 | 10.7 % | -2.86% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
94.8
%
| 90,004 | 95.5 % | 83,860 | 94.8 % | -6.83% |
Others
4.8
%
| 3,755 | 4.0 % | 4,281 | 4.8 % | +14.00% |
United States
0.4
%
| 484 | 0.5 % | 316 | 0.4 % | -34.75% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shang Cheol Shin
CEO | Chief Executive Officer | - | - |
Min-Seob Lee
CEO | Chief Executive Officer | 58 | 13-01-31 |
Sam Martin
PRN | Corporate Officer/Principal | 46 | 22-09-12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gyu-Yeon Lee
BRD | Director/Board Member | 60 | - |
Min-Seob Lee
CEO | Chief Executive Officer | 58 | 13-01-31 |
Sung Ho Kim
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 138,333,456 | 120,219,180 ( 86.91 %) | 81,806 ( 0.0591 %) | 86.91 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
216,159 | 0.16% | 75,785 $ |
Company contact information
EONE DIAGNOMICS GENOME CENTER Co., Ltd.
4F, 291 Harmony-ro Yeonsu-Gu
22014, Inchon
+
http://www.edgc.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-0.72% | 41.72M | |
+16.03% | 70.45B | |
+2.22% | 25.03B | |
+7.11% | 8.29B | |
-2.98% | 8.05B | |
-20.55% | 7.97B | |
+3.91% | 4.62B | |
+17.12% | 4.25B | |
-1.24% | 4.04B | |
-3.44% | 3.86B |
- Stock Market
- Equities
- A245620 Stock
- Company Eone Diagnomics Genome Center Co., Ltd.